Last updated: 2026-09-06 06:41:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Mannatech Inc. (MTEX) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $8,64, with a market capitalisation of $13,16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,80 to $12,45. This page covers its latest market performance, valuation, price trends and company information.
$13,16M | |
$8,05 | |
$261,00 | |
$3,14 | |
$7,29 | |
72,30K | |
-- | |
-- | |
$12,45 | |
$3,80 | |
-- | |
-- |
Mannatech Inc. (MTEX) last closed at $7,29 as of 2026-09-04 23:55:00, unchanged from the previous close of $7,29.
During the latest regular trading session, MTEX traded between $3,14 and $261,00, with a volume of 72,30K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Mannatech Inc. (MTEX) moved from $7,18 to $8,64, representing a gain of 20,33% ($1,46).
The stock traded between $7,03 and $9,10 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 67,01 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 55,9%
MTEX is currently trading at $8,64, placing it 55,9% of the way from its 52-week low of $3,80 to its 52-week high of $12,45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 170 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mannatech Inc. (MTEX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.